Browse EX-10 agreements

337326095 v2 1. CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is made by and between Ovid Therapeutics Inc. (the “Company”) and Karen Bernstein (“Consultant”) (each, a “Party”), effective as of June 10, 2026 (the “Effective Date”). 1. ENGAGEMENT OF SERVICES. Subject to the terms of this Agreement, Consultant agrees to provide consulting services to the Company as described in Exhibit A hereto (the “Services”). Consultant shall perform all Services in compliance with all applicable laws. 2. COMPENSATION. As sole compensation for the performance of the Services, the Company will pay to Consultant the amounts on the schedule specified in Exhibit A. 3. TERM AND TERMINATION. The term of this Agreement shall begin on the Effective Date and will automatically terminate on the first anniversary of the Effective Date (the “Term”); provided, however, that the Term of this Agreement may be renewed by the Company in its sole discretion. Either Party may terminate this Agreement earlier upon written notice if the other Party materially breaches this Agreement and, if such breach is curable, fails to cure such breach within ten (10) days after written notice specifying the breach. The Company may terminate this Agreement immediately upon written notice for Consultant’s fraud, willful misconduct, or conviction of, or plea of nolo contendere to, a felony. Upon any early termination, the Company will pay any earned but unpaid consulting fee through the effective date of termination and reimburse approved expenses. 4. INDEPENDENT CONTRACTOR RELATIONSHIP. Consultant’s

…

** **

AMENDEMENT

** **

Made and Signed on August 02, 2026

** **

TO CONSULTING AGREEMENT Dated March 18, 2025

** **

By and Between

** **

Duke Robotics Corp.

10 Ha’rimon St. Move Carmel Industrial and Science Park, 2069203

(Hereinafter “Company” or “Duke”)

And

Mr. Vadim Maor, ID No. 016959249

Maale Avshalom St 48, Kiryat Tiveon, Israel

(Hereinafter “Consultant”)

WHEREAS, The Company and the Consultant entered into a Consulting Agreement dated March 18, 2025 (hereinafter referred to as the “Agreement”);and

** **

WHEREAS, according to the Agreement the Company engages the Consultant as an independent consultant and the Consultant agreed to serve as a consultant to the Company and provide the Company consulting services as CTO; and

** **

WHEREAS, the Company and the Consultant desire to amend the Agreement as set forth in this Amendment;

NOW, THEREFORE, the Parties hereby agree as follows:

1.	Consultant Scope of the Services

Section 3 of the Agreement shall be replaced with the following new section 3:

“3. The scope of the Services’ hours shall be equivalent to a full-time position.

…

SECOND AMENDMENT TO SERVICES AGREEMENT

This second amendment to Services Agreement dated August 12, 2026 (the “Second Amendment”)by and between Duke Robotics Corp. (NV registered company) of 10 HaRimon Street, Mevo Carmel Science and Industrial Park, Israel (the “Company”) and Mr. Yossef Balucka of Ha’Sadot Road, Talmei Elazar, Israel (the “Consultant”).

R E C I T A L S:

---

	WHEREAS	the Company and the Consultant have entered into a consulting agreement dated March 25, 2021, for the rendering of CEO consulting services by the Consultant to the Company (the “Agreement”); and

** **

	WHEREAS	The Company and the Consultant amended the Agreement on August 4, 2024 (the “First Amendment”);and

** **

…

CANDEL Therapeutics, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of Candel Therapeutics, Inc. (the “Company”) is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its subsidiaries (“Outside Directors”). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

Cash Retainers

Annual Retainer for Board Membership: $40,000 for general availability and participation in meetings and conference calls of our Board of Directors, to be paid quarterly in arrears, pro-rated based on the number of actual days served by the director during such calendar quarter. No additional compensation will be paid for attending individual meetings of the Board of Directors.

…

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is made between Candel Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark Sims (the “Executive”) and is made effective as of July 6, 2026 (the “Effective Date”).

WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company on the terms and conditions contained herein; and

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.

Employment.

(a)

Term. The Company shall employ the Executive and the Executive shall be employed by the Company pursuant to this agreement commencing as of the Effective Date and continuing until such employment is terminated in accordance with the provisions hereof (the “Term”). The Executive’s employment with the Company shall be “at will,” meaning that the Executive’s employment may be terminated by the Company or the Executive at any time and for any reason subject to the terms of this Agreement.

(b)

…

EXECUTION VERSION

SECOND AMENDED AND RESTATED TERM LOAN AGREEMENT

Dated as of August 7, 2026

by and among

EACH OF THE PERSONS SIGNATORY HERETO AND NAMED ON ANNEX A,

ALLY BANK

for itself as a Lender and as Administrative Agent for all Lenders,

and

THE OTHER FINANCIAL INSTITUTIONS PARTY HERETO AS LENDERS

---

TABLE OF CONTENTS

| | | | | | | | | | | ------------------------------------------------- | - | ---- | : | ----------------------------------------------- | - | :------: | -: | - | | | | | | | | | | | | | | | | | | Page | | | | | | | | | | | | | | ARTICLE 1 DEFINITIONS; PRINCIPLES OF CONSTRUCTION | | | | | | | 2 | | | | | | | | | | | | | | | 1.1 | | Specific Definitions | | | 2 | |

…

​

Exhibit 10.15

MEIRAGTX HOLDINGS PLC

2026 EMPLOYMENT INDUCEMENT AWARD PLAN

RESTRICTED SHARE Unit Grant Notice

Capitalized terms not specifically defined in this Restricted Share Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the 2026 Employment Inducement Award Plan (as amended from time to time, the “Plan”) of MeiraGTx Holdings plc (the “Company”).

The Company has granted to the participant listed below (“Participant”) the Restricted Share Units described in this Grant Notice (the “RSUs”), subject to the terms and conditions of the Plan and the Restricted Share Unit Agreement attached as Exhibit A(the “Agreement”), both of which are incorporated into this Grant Notice by reference.

​	​
Participant:	​
Grant Date:	​
Number of RSUs:	​
Vesting Commencement Date:	​
Vesting Schedule:	[To be specified in individual award agreements]
​	​

​

…

MEIRAGTX HOLDINGS PLC****2026 EMPLOYMENT INDUCEMENT AWARD PLAN

​

OPTION GRANT NOTICE

Capitalized terms not specifically defined in this Option Grant Notice (the “Grant Notice”) have the meanings given to them in the 2026 Employment Inducement Award Plan (as amended from time to time, the “Plan”) of MeiraGTx Holdings plc (the “Company”).

The Company has granted to the participant listed below (“Participant”) the option described in this Grant Notice (the “Option”), subject to the terms and conditions of the Plan and the Option Agreement attached as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference.

​	​
Participant:	​
Grant Date:	​
Exercise Price per Share:	​
Shares Subject to the Option:	​
Final Expiration Date:	​

…

MEIRAGTX HOLDINGS PLC

2026 EMPLOYMENT INDUCEMENT AWARD PLAN

ARTICLE I.

** Purpose**

The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI.

ARTICLE II.

** Eligibility**

Eligible Individuals are eligible to be granted Awards under the Plan, subject to the limitations described herein.

ARTICLE III.

** Administration and Delegation**

3.1Administration.  The Plan is administered by the Administrator. The Administrator has authority to determine which Eligible Individuals receive Awards, grant Awards and set Award terms and conditions, subject to the conditions and limitations in the Plan. The Administrator also has the authority to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan or any Award as it deems necessary or appropriate to administer the Plan and any Awards. The Administrator may adopt procedures from time to time that are intended to ensure that an individual is an Eligible Individual prior to the granting of any Awards to such individual (including without limitation a requirement that each such individual certify to the Company prior

…

MeiraGTx Holdings plc

Non-Employee Director Compensation Program

(effective as of June 10, 2026)

Non-employee members of the board of directors (the “Board”) of MeiraGTx Holdings plc (the “Company”) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. As of its effectiveness, the terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors.

**I.**Cash Compensation

A.Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $90,000 for service on the Board.

B.Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers:

…

Certain information marked as [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.

​

REOGEN LIMITED (formerly known as Hologen Neuro AI Limited)

DEED OF AMENDMENT TO FRAMEWORK AGREEMENT

Dated as of June 22, 2026

​

This DEED is dated June 22, 2026 and is made by and among:

PARTIES

(1)	Hologen Limited, a non-cellular company limited by shares incorporated in Guernsey with company number 74905 whose registered office is at PO Box 650, 1st Floor, Royal Chambers, St. Julian’s Avenue, St. Peter Port, GY1 3JX, Guernsey (“Hologen”);

…

ACCELERANT HOLDINGS

ANNUAL BONUS PLAN

Adopted May 13, 2026

1.					General Plan Purpose and Structure

The purpose of the Accelerant Holdings Annual Bonus Plan (the “ABP”) is to motivate superior, focused, and prudent performance on the part of employees, including behaviors that drive collective success, for the ultimate benefit of shareholders and employees. The ABP is further intended to support the Company’s ability to attract and retain high-performing talent through competitive compensation, while providing flexibility in delivering appropriate incentive compensation opportunities tied to the achievement of company-wide goals.

2.					Definitions

The following words and phrases, when used below, unless the context clearly otherwise requires, shall have the following respective meanings:

…